osimertinib
astrazeneca
['adaura', 'lcsm,(-blcsm)', 'osimertinib', 'nsclc', 'sclc', 'aura ,(-laura)']
updated adaura data reinforce adjuvant osimertinib as soc for egfr-mutated, stage ib-iiia nsclc #esmo2022 #lcsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.